key: cord-1004812-pa6kr5eu authors: Highton, Patrick J.; Hadjiconstantinou, Michelle; Schreder, Sally; Seidu, Sam; Davies, Melanie; Khunti, Kamlesh title: COVID-19, Ethnicity and cardiometabolic disease self-management in UK primary care date: 2020-11-20 journal: Diabetes Metab Syndr DOI: 10.1016/j.dsx.2020.11.013 sha: 56a46d89f8e8b527bbc512fac50c1b7749a5b1d3 doc_id: 1004812 cord_uid: pa6kr5eu nan Cardiometabolic diseases (e.g. cardiovascular disease, diabetes, hypertension, chronic kidney disease) are the most prevalent chronic conditions globally and often co-occur (termed cardiometabolic multimorbidity), driving mortality 1 . Recent evidence highlights that pre-existing cardiometabolic comorbidities and poorly controlled cardiovascular risk factors are associated with adverse clinical outcomes among COVID-19 patients 2 . Cardiometabolic diseases are also significantly more prevalent in COVID-19 patients than other chronic conditions such as cancer or chronic obstructive pulmonary disease (10-23% vs 2-3%) 3 . Individuals with cardiometabolic disease are also at significantly elevated risk for COVID-19 related outcomes, including hospitalisation and death 4 . Additionally, individuals from ethnic minority backgrounds, particularly those from Black and South Asian populations, are at significantly greater risk of both COVID-19 infection and death, even after accounting for relevant socioeconomic factors which is partly driven by the increased cardiometabolic disease risk seen in these populations 5 . Furthermore, obesity and central adiposity, which are disproportionately common amongst Black and South Asian populations respectively 6 , drive adverse COVID-19 outcomes and mortality 7 . Consequentially, individuals from Black and South Asian backgrounds with pre-existing cardiometabolic disease and/or obesity represent an extremely vulnerable population with regards to adverse COVID-19-related outcomes. Furthermore, COVID-19 has had a profoundly negative impact on mental health due to elevated stress, depression and social isolation 8 , which may also disproportionately affect those from ethnic minority communities 9 and worsen multimorbidity-related health outcomes in the long-term 10 . Ongoing management of cardiometabolic disease including sufficient risk factor control and mental health support is vital to minimise this risk, particularly in ethnic minority groups. However, the COVID-19 pandemic has resulted in a dramatic shift of attention and resources away from chronic disease management, and has caused a huge disruption in routine NHS care for patients with chronic disease. Additionally, risk factor control may have been directly affected during COVID-19-related restrictions due to factors such worsened medication adherence 11 , impacted lifestyle behaviours including reduced physical activity, increased sedentary time and altered nutritional habits 12 , and disrupted sleep 13 . This is particularly pertinent for ethnic minority populations, who typically already display reduced physical activity levels 14 . Previous research from national disaster-events has highlighted that poor disease risk factor control during the disaster is associated with significantly worse long-term health outcomes 15 . Socioeconomic deprivation, which has been profoundly negatively impacted by COVID-related restrictions, is also more common in ethnic minority populations, driving healthcare access inequalities and increasing COVID-related mortality 16 . New pathways for prospective cardiometabolic risk factor control are therefore urgently required, not only for minimising cardiovascular disease-associated risk related to a possible second spike in COVID-19 infection rates 2 , but also for preventing adverse long-term outcomes associated with poor risk factor control during the COVID/post-COVID-era 15 . J o u r n a l P r e -p r o o f As such, there is a vital need to implement novel methods of supporting risk factor control and mental health for those with cardiometabolic multimorbidity in the COVID/post-COVID era, particularly for ethnic minority populations who display extremely high risk. Disease self-management (DSM) whereby the person is empowered to manage all or parts of their routine care in combination with shared decision-making supported by an integrated multidisciplinary care team, provides a promising avenue to address this need. DSM has demonstrated clinical and cost-effectiveness in chronic disease 17 , and can be implemented in a COVID-resilient manner using virtual platforms and support 18 . Typically, UK health-promoting services or interventions are not translated for ethnic minority populations, which strengthens pre-existing health inequalities. In order to be effective, DSM education programmes and support must be not only translated appropriately for UK ethnic minority populations, but also culturally-adapted from the ground-up to ensure that they are suitable in the cultural, social and religious context of the target population. The recent evidence concerning excess COVID-related risk in those both with pre-existing cardiometabolic conditions and those from UK ethnic minority communities has driven a large amount of research to be undertaken concerning possible underlying causes, factors associated with increased infection and adverse outcome risk, and impact on mental health. However, COVID-19 has resulted in a significant disruption in routine chronic disease care, particularly diabetes and cardiovascular disease, due to resource shift towards COVID-19 prevention or treatment, the difficulty in maintaining routine care with adequate social distancing, and impacted mental health 19 . Therefore, investigating new approaches to delivering routine chronic disease management in a COVID-resilient manner is crucial for the prevention of a severe detriment to future chronic disease outcomes 20 . However, to our knowledge there are no studies to date concerning specific COVIDresilient adaptation of DSM programmes to improve long-term physical and mental health outcomes. There is therefore an urgent need for such data, and exemplars from both within the UK and around the world upon which to base future models of care, particularly for minority ethnic health groups. Furthermore, a general reduction in the maintenance of adequate cardiometabolic risk factor control due to COVID-19 would result in significantly increased healthcare utilisation and costs, further straining already financially-pressured healthcare systems. We therefore recommend the following care priorities with regards to the management of the UK cardiometabolic disease population: 1. Stratify patients based on adverse long-term and COVID-related outcome risk in order to prioritise the review of the most at-risk patients during the COVID/post-COVID era. 2. Incorporate culturally-tailored COVID-resilient DSM programmes and shared decisionmaking in order to support chronic disease management (e.g. medication optimisation and adherence, nutritional habits, physical activity levels) whilst minimising healthcare burden. 5. Ensure the completion of regular patient reviews (virtually or otherwise) to support patients to manage their own conditions, identify issues as they arise and foster long-term behaviour change. These steps are vital, particularly in ethnic minority populations, in order to minimise the potential for excess deaths related to COVID-19 and future long-term adverse health outcomes, and further UK healthcare system strain. J o u r n a l P r e -p r o o f Association of cardiometabolic multimorbidity with mortality Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis Prevalence of Comorbidities and Their Association With Mortality in Patients With COVID-19: A Systematic Review and Meta-analysis Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome Disparities in the risk and outcomes of COVID-19 Overweight and obesity: prevalence, consequences, and causes of a growing public health problem Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom Diabetes and COVID 19: psychosocial consequences of the COVID 19 pandemic in people with diabetes in Denmark-what characterizes people with high levels of COVID 19 related worries? Diabetic Medicine COVID-19, mental health and ethnic minorities. Evidence-Based Mental Health The effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from LMICs Sanchis-Gomar F. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19) Dealing with sleep problems during home confinement due to the COVID 19 outbreak: Practical recommendations from a task force of the European CBT I Academy Race/ethnicity, social class and their relation to physical inactivity during leisure time: results from the Third National Health and Nutrition Examination Survey Diabetes and COVID-19: risks, management, and learnings from other national disasters Ethnicity, comorbidity, socioeconomic status, and their associations with COVID-19 infection in England: a cohort analysis of UK Biobank data A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Using Intervention Mapping to Develop a Digital Self-Management Program for People With Type 2 Diabetes: Tutorial on MyDESMOND Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study